Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms

David E Gordon1,2,3,4, Joseph Hiatt1,4,5,6,7, Mehdi Bouhaddou1,2,3,4

  • 1Quantitative Biosciences Institute (QBI) COVID-19 Research Group (QCRG), San Francisco, CA 94158, USA.

Science (New York, N.Y.)
|October 16, 2020
PubMed

Insights

This study reveals Tom70 as a key host factor interacting with SARS-CoV-1 and SARS-CoV-2, offering new targets for COVID-19 drug development. Understanding these viral-human interactions aids in combating coronavirus proliferation.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, poses significant global health and economic risks.
  • SARS-CoV-2 shares genetic and structural similarities with SARS-CoV-1 and MERS-CoV, suggesting conserved pathogenic mechanisms.

Purpose of the Study:

  • To conduct a comparative analysis of viral-human protein-protein interactions and protein localization across SARS-CoV-1, SARS-CoV-2, and MERS-CoV.
  • To identify host factors crucial for coronavirus proliferation through functional genetic screening.

Main Methods:

  • Comparative analysis of viral-human protein-protein interactions and viral protein localization.
  • Functional genetic screening to identify host factors impacting coronavirus proliferation.
  • Cryo-electron microscopy for structural characterization of protein interactions.

Main Results:

  • Identified Tom70, a mitochondrial chaperone, as a host factor interacting with SARS-CoV-1 and SARS-CoV-2 via the viral ORF9b protein.
  • Structurally characterized the interaction between Tom70 and SARS-CoV-2 ORF9b using cryo-electron microscopy.
  • Integrated host factor data with COVID-19 patient genetic and billing records to identify potential therapeutic strategies.

Conclusions:

  • Tom70 is a critical host factor involved in the replication of SARS-CoV-1 and SARS-CoV-2.
  • The identified viral-human interactions and host factors provide a basis for developing novel antiviral therapies.
  • Further molecular and clinical studies are warranted to explore the identified drug treatment potentials.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
24.7K
Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.6K
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.3K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.5K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
489